Creating genetic resistance to HIV

被引：34

作者：

Burnett, John C. ^{[1
]}

Zaia, John A. ^{[1
]}

Rossi, John J. ^{[1
]}

机构：

[1] City Hope Natl Med Ctr, Beckman Res Inst, Duarte, CA USA

来源：

CURRENT OPINION IN IMMUNOLOGY | 2012年 / 24卷 / 05期

关键词：

IMMUNODEFICIENCY-VIRUS TYPE-1; ZINC-FINGER NUCLEASES; MODIFIED T-CELLS; LENTIVIRAL VECTOR; CURRENT PROGRESS; CLINICAL-TRIAL; IN-VIVO; THERAPY; RIBOZYME; LYMPHOCYTES;

D O I：

10.1016/j.coi.2012.08.013

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

HIV/AIDS remains a chronic and incurable disease, in spite of the notable successes of combination antiretroviral therapy. Gene therapy offers the prospect of creating genetic resistance to HIV that supplants the need for antiviral drugs. In sight of this goal, a variety of anti-HIV genes have reached clinical testing, including gene-editing enzymes, protein-based inhibitors, and RNA-based therapeutics. Combinations of therapeutic genes against viral and host targets are designed to improve the overall antiviral potency and reduce the likelihood of viral resistance. In cell-based therapies, therapeutic genes are expressed in gene modified T lymphocytes or in hematopoietic stem cells that generate an HIV-resistant immune system. Such strategies must promote the selective proliferation of the transplanted cells and the prolonged expression of therapeutic genes. This review focuses on the current advances and limitations in genetic therapies against HIV, including the status of several recent and ongoing clinical studies.

引用

页码：625 / 632

页数：8

共 68 条

[1] Expansion of multipotent and lymphoid-committed human progenitors through intraceflular dimerization of Mpl [J].

Abdel-Azim, Hisharn ;

Zhu, Yuhua ;

Hollis, Roger ;

Wang, Xiuli ;

Ge, Shundi ;

Hao, Qian-Lin ;

Smbatyan, Goar ;

Kohn, Donald B. ;

Rosol, Michael ;

Crooks, Gay M. .

BLOOD, 2008, 111 (08) :4064-4074

[2] Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation [J].

Allers, Kristina ;

Huetter, Gero ;

Hofmann, Joerg ;

Loddenkemper, Christoph ;

Rieger, Kathrin ;

Thiel, Eckhard ;

Schneider, Thomas .

BLOOD, 2011, 117 (10) :2791-2799

[3] Anti-human immunodeficiency virus hematopoietic progenitor cell-delivered ribozyme in a phase I study: Myeloid and lymphoid reconstitution in human immunodeficiency virus type-1-infected patients [J].

Amado, RG ;

Mitsuyasu, RT ;

Rosenblatt, JD ;

Ngok, FK ;

Bakker, A ;

Cole, S ;

Chorn, N ;

Lin, LS ;

Bristol, G ;

Boyd, MP ;

Macpherson, JL ;

Fanning, GC ;

Todd, AV ;

Ely, JA ;

Zack, JA ;

Symonds, GP .

HUMAN GENE THERAPY, 2004, 15 (03) :251-262

[4] Human immunodeficiency virus type 1 restriction by human-rhesus chimeric tripartite motif 5α (TRIM 5α) in CD34+ cell-derived macrophages in vitro and in T cells in vivo in severe combined immunodeficient (SCID-hu) mice transplanted with human fetal tissue [J].

Anderson, Joseph ;

Akkina, Ramesh .

HUMAN GENE THERAPY, 2008, 19 (03) :217-228

[5] Preintegration HIV-1 Inhibition by a Combination Lentiviral Vector Containing a Chimeric TRIM5α Protein, a CCR5 shRNA, and a TAR Decoy [J].

Anderson, Joseph S. ;

Javien, John ;

Nolta, Jan A. ;

Bauer, Gerhard .

MOLECULAR THERAPY, 2009, 17 (12) :2103-2114

[6] Characterization of Anti-HIV Activity Mediated by R88-APOBEC3G Mutant Fusion Proteins in CD4+ T cells, Peripheral Blood Mononuclear Cells, and Macrophages [J].

Ao, Zhujun ;

Wang, Xiaoxia ;

Bello, Alexander ;

Jayappa, Kallesh Danappa ;

Yu, Zhe ;

Fowke, Keith ;

He, Xinying ;

Chen, Xi ;

Li, Junhua ;

Kobinger, Gary ;

Yao, Xiaojian .

HUMAN GENE THERAPY, 2011, 22 (10) :1225-1237

[7] In silico modeling indicates the development of HIV-1 resistance to multiple shRNA gene therapy differs to standard antiretroviral therapy [J].

Applegate, Tanya Lynn ;

Birkett, Donald John ;

Mcintyre, Glen John ;

Jaramillo, Angel Belisario ;

Symonds, Geoff ;

Murray, John Michael .

RETROVIROLOGY, 2010, 7

[8] Successful Targeting and Disruption of an Integrated Reporter Lentivirus Using the Engineered Homing Endonuclease Y2 I-AniI [J].

Aubert, Martine ;

Ryu, Byoung Y. ;

Banks, Lindsey ;

Rawlings, David J. ;

Scharenberg, Andrew M. ;

Jerome, Keith R. .

PLOS ONE, 2011, 6 (02)

[9] Computational Models of HIV-1 Resistance to Gene Therapy Elucidate Therapy Design Principles [J].

Aviran, Sharon ;

Shah, Priya S. ;

Schaffer, David V. ;

Arkin, Adam P. .

PLOS COMPUTATIONAL BIOLOGY, 2010, 6 (08)

[10] GENE-THERAPY - INTRACELLULAR IMMUNIZATION [J].

BALTIMORE, D .

NATURE, 1988, 335 (6189) :395-396

← 1 2 3 4 5 6 7 →